iRhythm Holdings (IRTC) Net Equity Issued and Repurchased (2015 - 2021)
iRhythm Holdings' (IRTC) quarterly Net Equity Issued and Repurchased came in at $80000.0 in Q3 2021, down 98.15% year-on-year from $4.3 million in Q3 2020, and down 98.0% on a QoQ basis from $4.0 million in Q2 2021.
iRhythm Holdings (IRTC) Net Equity Issued and Repurchased (2015 - 2021) Analysis & Trends
iRhythm Holdings (IRTC) has 6 years of Net Equity Issued and Repurchased data on file, last reported at $80000.0 in Q3 2021.
- On a quarterly basis, Net Equity Issued and Repurchased fell 98.15% year-over-year to $80000.0 in Q3 2021; TTM through Sep 2021 was $10.0 million, a 32.04% decrease from a year earlier, with the FY2015 full-year figure at $12.1 million, down 29.57% from the prior year.
- Net Equity Issued and Repurchased for Q3 2021 stood at $80000.0, down from $4.0 million in the prior quarter.
- Over the last five years, Net Equity Issued and Repurchased for IRTC reached as high as $6.4 million in Q2 2020 and fell as low as $35000.0 in Q1 2017.
- Historically, Net Equity Issued and Repurchased has averaged $2.4 million across 5 years, with a median of $2.1 million in 2019.
- Across the five-year window, Net Equity Issued and Repurchased jumped 2405.71% in 2018 and plunged 98.15% in 2021, its largest moves.
- Year by year, Net Equity Issued and Repurchased stood at $1.7 million in 2017, then fell by 6.92% to $1.6 million in 2018, then plunged by 38.08% to $1.0 million in 2019, then surged by 332.1% to $4.3 million in 2020, then plunged by 98.15% to $80000.0 in 2021.
- Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $80000.0 in Q3 2021, $4.0 million in Q2 2021, and $1.6 million in Q1 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 12.70 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | iRhythm Holdings | 3.50 Bn | 2.95 Bn | 141.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 80,000.00 |
| Sep 30, 2021 | 80,000.00 |
| Jun 30, 2021 | 4.00 Mn |
| Jun 30, 2021 | 4.00 Mn |
| Mar 31, 2021 | 1.58 Mn |
| Mar 31, 2021 | 1.58 Mn |
| Sep 30, 2020 | 4.32 Mn |
| Sep 30, 2020 | 4.32 Mn |
| Jun 30, 2020 | 6.39 Mn |
| Jun 30, 2020 | 6.39 Mn |
| Mar 31, 2020 | 2.97 Mn |
| Mar 31, 2020 | 2.97 Mn |
| Sep 30, 2019 | 1.00 Mn |
| Sep 30, 2019 | 1.00 Mn |
| Jun 30, 2019 | 3.29 Mn |
| Jun 30, 2019 | 3.29 Mn |
| Mar 31, 2019 | 2.12 Mn |
| Mar 31, 2019 | 2.12 Mn |
| Sep 30, 2018 | 1.62 Mn |
| Sep 30, 2018 | 1.62 Mn |